1. Home
  2. RDHL vs WTO Comparison

RDHL vs WTO Comparison

Compare RDHL & WTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • WTO
  • Stock Information
  • Founded
  • RDHL 2009
  • WTO 2008
  • Country
  • RDHL Israel
  • WTO China
  • Employees
  • RDHL N/A
  • WTO N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • WTO Consumer Electronics/Appliances
  • Sector
  • RDHL Health Care
  • WTO Technology
  • Exchange
  • RDHL Nasdaq
  • WTO Nasdaq
  • Market Cap
  • RDHL 3.9M
  • WTO 3.2M
  • IPO Year
  • RDHL N/A
  • WTO 2021
  • Fundamental
  • Price
  • RDHL $1.23
  • WTO $1.16
  • Analyst Decision
  • RDHL
  • WTO
  • Analyst Count
  • RDHL 0
  • WTO 0
  • Target Price
  • RDHL N/A
  • WTO N/A
  • AVG Volume (30 Days)
  • RDHL 1.4M
  • WTO 72.6K
  • Earning Date
  • RDHL 08-28-2025
  • WTO 08-12-2025
  • Dividend Yield
  • RDHL N/A
  • WTO N/A
  • EPS Growth
  • RDHL N/A
  • WTO N/A
  • EPS
  • RDHL N/A
  • WTO N/A
  • Revenue
  • RDHL $8,042,999.00
  • WTO $32,309,502.00
  • Revenue This Year
  • RDHL $381.91
  • WTO N/A
  • Revenue Next Year
  • RDHL N/A
  • WTO N/A
  • P/E Ratio
  • RDHL N/A
  • WTO N/A
  • Revenue Growth
  • RDHL 23.17
  • WTO 47.36
  • 52 Week Low
  • RDHL $1.17
  • WTO $0.75
  • 52 Week High
  • RDHL $15.34
  • WTO $622.50
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 33.65
  • WTO 55.56
  • Support Level
  • RDHL $1.17
  • WTO $1.01
  • Resistance Level
  • RDHL $3.31
  • WTO $1.26
  • Average True Range (ATR)
  • RDHL 0.31
  • WTO 0.12
  • MACD
  • RDHL -0.09
  • WTO -0.00
  • Stochastic Oscillator
  • RDHL 2.80
  • WTO 50.00

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

About WTO UTime Limited

UTime Ltd is engaged in the design, development, production, sales and brand operation of mobile phones, accessories and related consumer electronics. It also provides Electronics Manufacturing Services (EMS), including Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services, for renowned brands. The company operates in China and its products are sold globally, including Mexico, Brazil, the United States, and other emerging markets in South Asia and Africa as well as Europe. It has two in-house brands, UTime, known as its middle-to-high end label and targets middle class consumers from emerging markets; and Do, as its low- to mid-end brand, is positioned to the grassroots consumers and price-sensitive consumers in emerging markets.

Share on Social Networks: